title: [Recurrence of hepatocellular carcinoma and its treatment].
authors.forename: H
authors.initials: H
authors.lastname: Komechi
authors.forename: H
authors.initials: H
authors.lastname: Tutui
authors.forename: T
authors.initials: T
authors.lastname: Aramaki
authors.forename: T
authors.initials: T
authors.lastname: Ohoya
authors.forename: T
authors.initials: T
authors.lastname: Kumazaki
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D000431:Ethanol / Q000008:administration & dosage; D006526:Hepatitis C / Q000150:complications / Q000628:therapy; D006801:Humans; D015552:Injections, Intralesional; D016898:Interferon-alpha / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D000431:Ethanol